Showing results (261-270 of 391) with videos related to
Sort By:
Pageof 40
Journal of Medicinal Chemistry|February 17, 2022
Contemporary Medicinal Chemistry Strategies for the Discovery and Development of Novel HIV-1 Non-nucleoside Reverse Transcriptase InhibitorsZhao Wang, Srinivasulu Cherukupalli, Minghui Xie, et al.Medicinal Research Reviews|April 20, 2019
Molecular design opportunities presented by solvent-exposed regions of target proteinsXiangyi Jiang, Ji Yu, Zhongxia Zhou, et al.Journal of Medicinal Chemistry|December 8, 2025
Design, Synthesis, and Biological Evaluation of Highly Potent Boronic Acid (Boronate Ester)-Bearing Heteroaryldihydropyrimidine Derivatives as HBV Capsid Assembly ModulatorsYu Jin, Yang Sun, Shujie Zhao, et al.Bioorganic & Medicinal Chemistry|August 14, 2012
Arylazolyl(azinyl)thioacetanilides. Part 10: design, synthesis and biological evaluation of novel substituted imidazopyridinylthioacetanilides as potent HIV-1 inhibitorsXiao Li, Peng Zhan, Hong Liu, et al.Bioorganic & Medicinal Chemistry|November 27, 2013
Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIsLingzi Zhang, Peng Zhan, Xuwang Chen, et al.Bioorganic & Medicinal Chemistry|June 5, 2021
Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant virusesZhipeng Fu, Tao Zhang, Zhongxia Zhou, et al.European Journal of Medicinal Chemistry|March 23, 2020
In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBPDongwei Kang, Da Feng, Lanlan Jing, et al.Molecules (Basel, Switzerland)|November 11, 2022
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase InhibitorsDa Feng, Hao Lin, Liyang Jiang, et al.Journal of Medical Virology|July 25, 2023
Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza virusesPing Li, Han Ju, Ying Zhang, et al.ACS Infectious Diseases|July 4, 2020
Structure-Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIsDongwei Kang, Yanying Sun, N Arul Murugan, et al.Pageof 40